fbpx

Immunology

Our research is focused on the role of the immune system and how it relates and can be used to treat cancer. In the future, cancer will predominately be treated with the activation of the immune system, without chemotherapy and radiation. We are undertaking studies on the immunology of cancer and the role of T […]

Read More…

Ovarian Cancer

Every 11 hours one woman dies of ovarian cancer in Australia. Approximately 1400 Australia women are diagnosed with the cancer each year, and nearly 800 die annually, making ovarian cancer the fourth most common cause of cancer-related death in women in Australia. The high mortality rate in ovarian cancer patients results from the diagnosis of […]

Read More…

Chronic Lymphocytic Leukemia (CLL)

CLL is the most common type of leukemia in adults in the Western world. There is evidence that genetic components contribute to the aetiology of CLL, but no definitive susceptibility genes have been identified. This project is studying the role of immune cells in the regulation of disease progression. The Institute is in a unique […]

Read More…

Langerhans Cell Histocytosis

A major field of our research is directed towards understanding the basic biology of histiocytic diseases. We have been studying a human form of histiocytosis called Langerhans cell histiocytosis (LCH) for many years. In this disease, cells called Langerhans cells accumulate in various tissues to form cancer-like lesions. The causes and mechanisms controlling the development […]

Read More…

Bowel cancer

Bowel cancer research conducted at the Fiona Elsey Cancer Research Institute in Ballarat, has discovered that a subset of immune cells in the bowel can misbehave and release chemical messengers that promote bowel cancer and inhibit other immune cells. Australia has one of the highest rates of Bowel cancer in the world. It is the […]

Read More…